All In Biotech

Drug Trial Radar · NCT06036927

A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps.

Last checked: Nov 20, 2026Latest source record: Apr 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Dec 8, 2023

Primary completion

Feb 5, 2025

Study completion Mar 27, 2025

Sponsor

Sponsor type
Industry
First posted
Sep 14, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate the efficacy, safety and pharmacokinetics of TQC2731 injection in the treatment of Chronic Sinusitis with Nasal Polyps.

Conditions

  • Chronic Sinusitis
  • Nasal Polyps

Interventions

  • TQC2731 injectionDrug

    TQC2731 injection is a thymic stromal lymphopoietin (TSLP) monoclonal antibody.

  • TQC2731 matching placeboDrug

    It'a a placebo injection without active substances.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Nasal Polyp Score (NPS)Time frame: Baseline up to 24 weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, Anhui, China

  • ZhuJiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Jieyang People's Hospital

    Jieyang, Guangdong, China

  • The Fifth Affiliated Hospital Sun Yat-sen University

    Zhuhai, Guangdong, China

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, China

  • Cangzhou Central Hospital

    Cangzhou, Hebei, China

  • Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

  • Affiliated Zhongshan Hospital Of Dalian University

    Dalian, Liaoning, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China

  • Weifang Second People's Hospital

    Weifang, Shandong, China

  • Eye & ENT Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

  • Chengdu Second People's Hospital

    Chengdu, Sichuan, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang Uygur Autonomous Region, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.